Can a new drug combo outperform standard care for a common type of heart failure?
Disease control
Recruiting now
This trial is testing whether sacubitril/valsartan, a newer heart failure medication, can improve heart function and reduce harmful heart remodeling better than the older drug ramipril. The study enrolls adults with ischemic heart failure (caused by reduced blood flow to the hear…
Phase: PHASE3 • Sponsor: John Paul II Hospital, Krakow • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC